14th Tumour Models Summit London 2025, December 3-4, 2025

Conference

genOway presentation

Event
-
December 3, 2025

genOway's presentation:

🕒 Wednesday, December 3, 2025 | 3.30 p.m. GMT

🎤 Fabiane Sônego, Director - Preclinical Models & Services

Advancing translational immuno-oncology: tumor–immune dynamics and predictive humanized models for immunotherapies

  • Highlighting the recruitment dynamics of human immune subsets within the tumor microenvironment in humanized mice
  • Harnessing the role of human myeloid and lymphoid cells to investigate tumor biology and therapeutic efficacy
  • Showcasing the critical role of myeloid cells in therapy-related immune-related adverse events (IrAEs)

14th Tumour Models Summit London 2025, December 3-4, 2025

Get in touch

Let us know how we can help

Other news & events

Lunch & Learn, May 7th: Accelerating Drug Development Through Predictive and Translatable In Vivo Models
genOway presentation
Event
-
May 2026
Read on
genOway Shanghai at Bionnava China 2026
Conference
Event
-
Apr 2026
Read on
genOway Shanghai at AntibodyChina 2026: The 9th Antibody Therapeutics & ADC Focus Summit
Conference
Event
-
Apr 2026
Read on
AACR Annual Meeting 2026, San Diego, CAL, April 17-22
Conference
genOway presentation
Event
-
Mar 2026
Read on
Revolutionizing the Prediction of Antibody Therapies in Humans with a Unique Mouse Model
Partnership
News
-
Feb 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe